Nasdaq:US$13.74 (-0.46) | HKEX:HK$22.10 (-1.00) | AIM:£2.34 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 9 Oct 2013

Chi-Med’s Pharmaceutical R&D Business – Analyst & Investor Briefing